Interestingly, inhibitory targeting of the HSP90 chaperone function may not only suppress EMT together with EMT-evoked CSC accumulation but also may reverse the cancer cell stemness by inducing MET in existing CSCs (both opportunities are designated in Figure 1). Here, HSP90AB1 is linked to cancer.